logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Steven Simoens

ku leuven

64H指数
691论文数
1.6W被引数
收录论文 206
发表时间
logo
Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries欧盟国家中囊性纤维化调节剂疗法报销的时机与比例
errJournal of Cystic Fibrosis
IF6
err2026-07-21
err0
errOAAI
errEnrico Costa; Silvia Girotti; Saif Elayan; Carlo Castellani; Maria Cavaller Bellaubi; Wim Goettsch; Momir Radulović; João Rocha; Pierluigi Russo; Steven Simoens; Christine Leopold
err分享
err收藏
Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time-series analysis探索欧洲视网膜疾病生物制剂（包括生物类似药）治疗的市场动态：一项中断时间序列分析
errActa Ophthalmologica
IF2.8
err2026-04-30
err0
errOAAI
errElif Car; Isabelle Huys; Steven Simoens; Arnold G. Vulto
err分享
err收藏
Addressing clinical uncertainties in ATMP reimbursement: a review of methodological guidelines and European practice解决ATMP报销中的临床不确定性：方法学指南与欧洲实践的综述
errFrontiers in Pharmacology
IF4.8
err2026-03-12
err0
errOAAI
errLD Lotte Delemarre; IH Isabelle Huys; WV Walter Van Dyck; SS Steven Simoens
err分享
err收藏
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening确保风险分层癌症筛查模型中的流行病学一致性：一种基于Flemish乳腺癌筛查的全新方法
errApplied Health Economics and Health Policy
IF3.3
err2026-02-17
err0
PREAI
errMax Lelie; Bo VandenBulcke; Nick Verhaeghe; Lieven Annemans; Steven Simoens; Koen Putman
err分享
err收藏
The health production model and the crucial role of health promotion健康生产模型与健康教育促进的关键作用
errEXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
IF1.5
err2025-11-01
err0
PREAI
errAnnemans, Lieven; Aeyels, Daan; Bejjani, Gilbert; Briganti, Giovanni; Broeckx, Dirk; Devisch, Ignaas; Verdonck, Pascal; Simoens, Steven
err分享
err收藏
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study迈向监管趋同与简化的生物类似药开发：一项国际定性研究的建议
errBioDrugs
IF6.9
err2025-10-21
err0
errOAAI
errElif Car; Liese Barbier; Ingrid Schwarzenberger; Isabelle Huys; Steven Simoens; Arnold G. Vulto
err分享
err收藏
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute development杜氏肌营养不良症基因疗法的偏好：来自患者和照护者访谈及属性开发的见解
errFrontiers in Pharmacology
IF4.8
err2025-09-29
err0
errOAAI
errThomas Desmet; Lauren Van Haesendonck; Sophie Vermeire; Eline van Overbeeke; Steven Simoens; Isabelle Huys
err分享
err收藏
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies更正：数据系统追踪药物利用的未开发潜力：改善肿瘤学联合疗法可及性的机会
errFrontiers in Pharmacology
IF4.8
err2025-09-05
err0
errOAAI
errSteven Simoens; David Dodwell; Michael Hartevelt; Peter Lindgren; Michele Pistollato; Lisa G. Pont; Caridad Pontes; Alexander Roediger; Antun Sablek; Eric Van Ganse; Qinyi Wang; Chris Wenger; Tim Wilsdon; Entela Xoxi; Brian Godman
err分享
err收藏
Barriers to adoption of biosimilar insulins in Europe: A mixed-methods study欧洲生物类似物胰岛素的采用障碍：一项混合方法研究
errdiabetes obesity metabolism
IF0
err2025-09-01
err0
errOAAI
errElif Car MSc; Garm Habets MSc; Arnold G. Vulto PhD; Lutz Heinemann PhD; Isabelle Huys PhD; Steven Simoens PhD
err分享
err收藏
Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscape先进治疗 medicinal products 正在走向成熟：临床 trial 研发管线分析
errDrug Discovery Today
IF7.5
err2025-08-23
err0
PREAI
errMichiel Vanhaeren; Rik Gijsbers; Walter Van Dyck; Isabelle Huys; Steven Simoens
err分享
err收藏
The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies数据系统追踪药品利用的未开发潜力：改善肿瘤学联合疗法可及性的一个机会
errFrontiers in Pharmacology
IF4.8
err2025-08-20
err0
errOAAI
errSteven Simoens; David Dodwell; Michael Hartevelt; Peter Lindgren; Michele Pistollato; Lisa Pont; Caridad Pontes; Alexander Roediger; Antun Sablek; Eric Van Ganse; Qinyi Wang; Chris Wenger; Tim Wilsdon; Entela Xoxi; Brian Godman
err分享
err收藏
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences强制许可作为应对高药价的一种工具：工业与健康后果的现实主义综述
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2025-04-19
err0
PREAI
errSimoens, Steven; Van Dyck, Walter; Janssens, Rosanne; Barbier, Liese; Luyten, Jeroen
err分享
err收藏
Caregivers and multidisciplinary team members' perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study
errORPHANET JOURNAL OF RARE DISEASES
IF3.5
err2025-03-10
err0
errOAAI
errSchoefs, Elise; Desmet, Thomas; Lerinckx, Evelyn; De Waele, Liesbeth; Geuens, Sam; Pelicaen, Conny; Meeus, Luc; Simoens, Steven; Van Audenhove, Chantal; Mommen, Mieke; Janssens, Rosanne; Huys, Isabelle
err分享
err收藏
Drawing on collective action theory to foster sustainable biosimilar markets - insights from co-creation workshops with UK and Belgian stakeholders
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2025-03-01
err0
PREAI
errLacosta, Teresa Barcina; Vulto, Arnold G.; Turk, Florian; Huys, Isabelle; Simoens, Steven
err分享
err收藏
Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review视网膜疾病的临床与社会经济负担：生物类似药能否增加价值？——一篇叙述性综述
errOPHTHALMOLOGY AND THERAPY
IF3.2
err2025-02-26
err0
errOAAI
errHariprasad, Seenu M.; Holz, Frank G.; Asche, Carl V.; Issa, Amine; Mora, Oriol; Keady, Simon; Rezk, Mourad F.; Sarocco, Phil; Simoens, Steven
err分享
err收藏
What role for real-world evidence in market access of biosimilars?真实世界证据在生物类似药市场准入中的作用？
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-02-24
err0
errOAAI
errSimoens, Steven; Lockhart, Catherine M.; Courmier, Delphine F.
err分享
err收藏
Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant
errFRONTIERS IN PUBLIC HEALTH
IF3.4
err2025-02-03
err0
errOAAI
errMarbaix, Sophie; Simoens, Steven; Clevenbergh, Philippe; Van Bleyenbergh, Pascal; Liberman, Keliane; Dehenau, Dimitri
err分享
err收藏
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews关于在欧洲为高成本、治愈性疗法的报销实施新支付模式的探讨：半结构化访谈的见解
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-01-20
err0
errOAAI
errDesmet, Thomas; Michelsen, Sissel; van den Brande, Elena; Van Dyck, Walter; Simoens, Steven; Huys, Isabelle
err分享
err收藏
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
errPHARMACEUTICAL MEDICINE
IF4.5
err2024-11-29
err0
errOAAI
errCar, Elif; Vandenplas, Yannick; Lacosta, Teresa Barcina; Simoens, Steven; Huys, Isabelle; Vulto, Arnold G.; Barbier, Liese
err分享
err收藏
The broader benefits of vaccines: methodologies for inclusion in economic evaluation
errEXPERT REVIEW OF VACCINES
IF4.8
err2024-09-04
err1
errOAAI
errSimoens, Steven; Tubeuf, Sandy; Dauby, Nicolas; Ethgen, Olivier; Marbaix, Sophie; Willaert, Marjan; Luyten, Jeroen
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Giuseppe Remuzzi
H 指数: 201 · 论文数: 2.1K
S
Stefan Schreiber
H 指数: 192 · 论文数: 1.9K
S
Séverine Vermeire
H 指数: 163 · 论文数: 2.4K
P
Paul Emery
H 指数: 158 · 论文数: 1.6K
S
Silvio Danese
H 指数: 139 · 论文数: 2.3K
查看更多